The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2) - Takeaways - MDSpire

The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2)

  • By

  • Naji Riachi

  • Ahmed Shatila

  • Sehriban Diab

  • Hasan Jaber

  • Mais Jawhari

  • Joseph G Mattar

  • Jean-Pascal Lefaucheur

  • Moussa A Chalah

  • Samar S Ayache

  • January 22, 2026

Share

  • 1

    The EXOPULSE Mollii Suit is a full-body garment designed to provide neuromodulation for fibromyalgia through 58 electrodes.

  • 2

    In a double-blind, randomized, sham-controlled trial, the suit significantly reduced Fibromyalgia Impact Questionnaire scores after active treatment.

  • 3

    Secondary outcomes showed improvements in pain, anxiety, depression, and quality of life following the use of the Mollii Suit.

  • 4

    No severe adverse events were reported during the study, indicating the safety of the EXOPULSE Mollii Suit.

  • 5

    The study supports the potential of the Mollii Suit as a home-based therapy for fibromyalgia, warranting further large-scale research.

Original Source(s)

The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2)

  • by Naji Riachi, Ahmed Shatila, Sehriban Diab, Hasan Jaber, Mais Jawhari, Joseph G Mattar, Jean-Pascal Lefaucheur, Moussa A Chalah, Samar S Ayache

  • January 22, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

What's Really Driving Arthritis Pain?

A narrative review suggests pain in rheumatoid arthritis and osteoarthritis extends beyond nociceptive mechanisms.

Knee Osteoarthritis Pain Linked to Glycemic Control

Painful knee OA was associated with lower likelihood of achieving glycemic targets in adults with T2D.